HLVX Overview

Tender Offer Completion: XOMA Royalty Corporation successfully completed its tender offer to acquire all outstanding shares of HilleVax, Inc. for $1.95 per share in cash, along with a non-tradeable contingent value right, with approximately 77.48% of HilleVax shares validly tendered.

Merger and Delisting: Following the tender offer, HilleVax merged with a subsidiary of XOMA Royalty, becoming a wholly owned subsidiary, and its shares will cease trading on Nasdaq and be delisted.

Investigation by Halper Sadeh LLC: The law firm is investigating Couchbase, HilleVax, and AvidXchange for potential violations of federal securities laws and breaches of fiduciary duties to shareholders related to their sales.

Couchbase Sale Details: Couchbase, Inc. is being sold to Haveli Investments for $24.50 per share in cash.

HilleVax Transaction Terms: HilleVax, Inc. will be sold to XOMA Royalty Corporation, offering stockholders $1.95 in cash per share along with a contingent value right for additional payments under certain conditions.

Legal Support for Shareholders: Halper Sadeh LLC offers free consultations to shareholders regarding their legal rights and may seek increased compensation or disclosures on behalf of the shareholders involved in these transactions.

Investigation Announcement: Former Louisiana Attorney General Charles C. Foti, Jr. and Kahn Swick & Foti, LLC are investigating the proposed sale of HilleVax, Inc. to XOMA Royalty Corporation.

Transaction Details: Shareholders of HilleVax would receive $1.95 in cash per share along with a non-transferable contingent value right for potential additional payments.

Concerns Raised: KSF is assessing whether the offered consideration adequately reflects the company's value and if the sales process was appropriate.

Contact Information: Interested parties can reach out to KSF Managing Partner Lewis S. Kahn for discussions regarding their legal rights related to the sale.

Investigation of Companies: Halper Sadeh LLC is investigating Aris Water Solutions, HilleVax, and American Woodmark for potential violations of federal securities laws related to their recent sales and transactions, urging shareholders to understand their rights and options.

Legal Support Offered: The law firm offers legal representation on a contingent fee basis, meaning shareholders will not incur out-of-pocket costs, and encourages them to contact the firm for assistance regarding their legal rights.

Investigation of Companies: Halper Sadeh LLC is investigating Aris Water Solutions, Y-mAbs Therapeutics, and HilleVax for potential violations of federal securities laws related to their recent sales and transactions, seeking increased consideration and disclosures for shareholders.

Legal Support for Shareholders: The law firm offers free consultations to affected shareholders, emphasizing that they will handle cases on a contingent fee basis, meaning no upfront costs for legal fees or expenses.

Investor Rights Investigation: Halper Sadeh LLC is investigating potential violations of federal securities laws and breaches of fiduciary duties related to the sales and mergers involving Steelcase Inc., HilleVax, BioSig Technologies, and Titan Pharmaceuticals, urging shareholders to explore their legal rights.

Legal Support Offered: The firm offers contingent fee-based legal representation for affected shareholders, emphasizing that they will not incur out-of-pocket expenses for legal fees or costs while seeking increased consideration and disclosures in the proposed transactions.